Free Trial

Purkiss Capital Advisors LLC Invests $361,000 in Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Purkiss Capital Advisors LLC acquired a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,975 shares of the company's stock, valued at approximately $361,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. State Street Corp raised its stake in Colgate-Palmolive by 3.8% in the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after buying an additional 1,784,411 shares during the period. Geode Capital Management LLC increased its holdings in shares of Colgate-Palmolive by 2.8% during the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock worth $2,095,325,000 after acquiring an additional 552,949 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in Colgate-Palmolive by 6.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock valued at $988,997,000 after acquiring an additional 557,492 shares during the period. Barclays PLC lifted its holdings in Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after purchasing an additional 2,132,747 shares during the last quarter. Finally, FMR LLC boosted its position in Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company's stock worth $700,642,000 after purchasing an additional 2,674,807 shares during the period. 80.41% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CL has been the subject of a number of research reports. Wells Fargo & Company cut their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research note on Tuesday, January 7th. TD Cowen lowered their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. Raymond James reaffirmed an "outperform" rating and set a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Royal Bank of Canada reiterated a "sector perform" rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, Piper Sandler reduced their price target on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, Colgate-Palmolive has an average rating of "Moderate Buy" and an average target price of $101.61.

Read Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Trading Up 0.9 %

NYSE CL traded up $0.81 on Wednesday, reaching $91.87. The company had a trading volume of 3,446,390 shares, compared to its average volume of 4,102,023. The firm has a market cap of $74.56 billion, a price-to-earnings ratio of 26.10, a P/E/G ratio of 4.20 and a beta of 0.44. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The business has a 50 day moving average of $88.73 and a two-hundred day moving average of $95.29.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the business earned $0.87 earnings per share. Analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.18%. Colgate-Palmolive's payout ratio is currently 56.82%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla Sinks on Musk Drama—Bounce or Bigger Crash?
3 AI Stocks to Watch After NVIDIA’s Dip
Congress Cashes In on Stocks—Here’s How You Can Too!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines